Por motivos de mantenimiento se ha deshabilitado el inicio de sesión temporalmente. Rogamos disculpen las molestias.
Artículo
Enantioselective synthesis of 4-amino-3,4-dihydrocoumarins and their non-cyclic hydroxyester precursors: Biological evaluation for the treatment of glioblastoma multiforme
Autor/es | Borrego Sánchez de la Cuesta, Lorenzo Gabriel
Recio Jiménez, Rocío Moreno Rodríguez, Nazaret Chelouan, Ahmed Álvarez, Eleuterio Sánchez Coronilla, Antonio Caro Salazar, Carlos Pearson, John R. García-Martín, María Luisa Khiar, Noureddine Fernández Fernández, Inmaculada |
Departamento | Universidad de Sevilla. Departamento de Química Orgánica y Farmacéutica Universidad de Sevilla. Departamento de Química Física |
Fecha de publicación | 2022 |
Fecha de depósito | 2023-05-12 |
Publicado en |
|
Premios | Premio Mensual Publicación Científica Destacada de la US. Facultad de Farmacia |
Resumen | The stereoselective addition of ethyl acetate enolate to the C═N bond of N-tert-butylsulfinylimines has been investigated in depth. A significant effect of the LHMDS amount and the N-sulfinylimine nature on the stereoselectivity ... The stereoselective addition of ethyl acetate enolate to the C═N bond of N-tert-butylsulfinylimines has been investigated in depth. A significant effect of the LHMDS amount and the N-sulfinylimine nature on the stereoselectivity of the process was observed. Conditions were found where sulfinylimines of differently substituted salicylaldehydes derivatives, ethyl acetate, and LHMDS afforded the corresponding addition products as a single diastereomer in good yields. The developed protocol was successfully applied to the first stereoselective synthesis of differently substituted 4-amino-3,4-dihydrocoumarin derivatives. Computational models confirmed the prominent role of the ortho aryl substituent in the stereoselectivity of the process. A significant and selective cytotoxic activity against Glioblastoma Multiforme (GBM) cancer line has been determined for the noncyclic hydroxy ester derivative. |
Agencias financiadoras | Ministerio de Ciencia, Innovación y Universidades (MICINN). España Junta de Andalucía |
Identificador del proyecto | PID2019-104767RB-I00
US-1381590 FQM-106 |
Cita | Borrego Sánchez de la Cuesta, L.G., Recio Jiménez, R., Moreno Rodríguez, N., Chelouan, A., Álvarez, E., Sánchez Coronilla, A.,...,Fernández Fernández, I. (2022). Enantioselective synthesis of 4-amino-3,4-dihydrocoumarins and their non-cyclic hydroxyester precursors: Biological evaluation for the treatment of glioblastoma multiforme. European Journal of Medicinal Chemistry, 243. https://doi.org/10.1016/j.ejmech.2022.114730. |
Ficheros | Tamaño | Formato | Ver | Descripción |
---|---|---|---|---|
Enantioselective synthesis of 4.pdf | 6.255Mb | [PDF] | Ver/ | |